Inclusion Criteria:

- Breast cancer scheduled for neoadjuvant chemotherapy followed by surgery

Exclusion criteria:

- Indicated chemotherapy without that a curative tumorectomies is foreseen(planned)

- Patient presenting an evolutionary infectious or inflammatory pathology, including an
inflammatory breast cancer, being able to be source(spring) of false-positive
results(profits) in TEP-FDG

- Patient in the course of radiotherapy or of chemotherapy or operated at the level of
the thorax in 4 weeks preceding the date foreseen(planned) by the examination TEP
(pose(installation) of implantable room(chamber) excludes)

- Diabetic waits

- Patient already includes in the other protocols of search(research) for Nuclear
Medicine or for imaging using ionization radiations

- Patient not having given her lit(enlightened) assent

- Wait among which the surveillance TEP or the MRI during the chemotherapy will be
impossible (that is by geographical or professional imperative, or if
contraindication in the MRI, ex: port(bearing) of a pacemaker, cochlear magnetic
implants, metal foreign bodies cf protocol)

- Of less than 18 years old or pregnant patient.

- Breast cancer stage(stadium) IV

- Biopsy on the already realized mammary tumor, for the period(delay) lower than 15 j.

- In case of alcoholic poisoning or of antecedents of reaction to the injection of
ethanol: not inclusion to be discussed.